Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cuentos japoneses
2
Samurai
2
Antropología
1
Arqueología
1
Arqueología urbana
1
Artes marciales
1
Aspectos ambientales
1
Bushido
1
Ciencia militar
1
Comprensión de lectura
1
Descripciones y viajes
1
Descripción y viajes
1
Eduardo Lizalde
1
El tigre en la casa
1
Ensayo
1
Ensayos japoneses
1
Geishas
1
Historia
1
Historia oriental
1
Homosexuales
1
Indígenas de México
1
Lectores (Adultos)
1
Literatura española
1
Literatura japonesa
1
Ninja
1
Novela alemana
1
Novela estadounidense
1
Nuevos lectores alfabetizados
1
Relaciones con España
1
Relaciones con Japón
1
-
21por Zhang, Jinping, Zhong, Yongzhi, Tang, Rui, Rebijith, K. B., Li, Fengqi, Chen, Guohua, Zhang, Feng“…The samurai wasp, Trissolcus japonicus, is the predominant egg parasitoid of the brown marmorated stink bug, Halyomorpha halys, in its native range in China. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
22“…A promising management tactic for the species is to release an associated parasitoid, the samurai wasp, Trissolcus japonicus. Populations of the samurai wasp have begun to adventively establish in several regions, including Pennsylvania. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23por Loo, Li Shen, Plato, Brian M., Turner, Ira M., Case, Michael G., Raskin, Joel, Dowsett, Sherie A., Krege, John H.“…BACKGROUND: We studied the efficacy and safety of a second dose of lasmiditan for acute treatment of migraine. METHODS: SAMURAI and SPARTAN were double-blind, placebo-controlled Phase 3 studies in which individuals with migraine were randomized to oral lasmiditan 50 mg (SPARTAN only), 100 mg, 200 mg, or placebo. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24por Loo, Li Shen, Ailani, Jessica, Schim, Jack, Baygani, Simin, Hundemer, Hans-Peter, Port, Martha, Krege, John H.“…Lasmiditan efficacy and safety measures were similar for patients using and not using preventive medications. TRIAL REGISTRATION: SAMURAI (NCT02439320) and SPARTAN (NCT02605174). Registered 18 March 2015. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
25
-
26
-
27por McKay, Rana“…We have therefore estimated a one-year nrPFS rate of 50% in the control (immunotherapy alone) arm for SAMURAI. We expect nephrectomies to contribute only a small fraction to the total nrPRS events. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
28por Hakoda, Akitoshi, Takeuchi, Toshihisa, Kojima, Yuichi, Fujiwara, Yasuhiro, Nagami, Yasuaki, Naito, Yuji, Fukuda, Shinsaku, Koike, Tomoyuki, Sugimoto, Mitsushige, Hamada, Kenta, Kobara, Hideki, Yoshida, Norimasa, Inaba, Tomoki, Nagahara, Akihito, Koizumi, Eriko, Murakami, Kazunari, Furuta, Takahisa, Ogasawara, Naotaka, Isomoto, Hajime, Shibagaki, Kotaro, Kataoka, Hiromi, Suzuki, Hidekazu, Higuchi, Kazuhide“…In conclusion, use of the SAMURAI model will allow proactive management of post-ESD bleeding risk in patients receiving antithrombotic therapy.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
29por Pilipenko, Pavel, Ivanova, Anna Andreevna, Kotsiubinskaya, Yulia Vadimovna, Feigin, Valery, Majdan, Marek, Grigoryeva, Vera Naumovna, Khrulev, Alexey YevgenievichEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
30por Tanzawa, Shigeru, Ushijima, Sunao, Shibata, Kazuhiko, Shibayama, Takuo, Bessho, Akihiro, Kaira, Kyoichi, Misumi, Toshihiro, Shiraishi, Kenshiro, Matsutani, Noriyuki, Tanaka, Hisashi, Inaba, Megumi, Haruyama, Terunobu, Nakamura, Junya, Kishikawa, Takayuki, Nakashima, Masanao, Iwasa, Keiichi, Fujiwara, Keiichi, Kohyama, Tadashi, Kuyama, Shoichi, Miyazawa, Naoki, Nakamura, Tomomi, Miyawaki, Hiroshi, Ishida, Hiroo, Oda, Naohiro, Ishikawa, Nobuhisa, Morinaga, Ryotaro, Kusaka, Kei, Fujimoto, Nobukazu, Yokoyama, Toshihide, Gemba, Kenichi, Tsuda, Takeshi, Nakagawa, Hideyuki, Ono, Hirotaka, Shimizu, Tetsuo, Nakamura, Morio, Kusumoto, Sojiro, Hayashi, Ryuji, Shirasaki, Hiroki, Ochi, Nobuaki, Aoe, Keisuke, Kanaji, Nobuhiro, Kashiwabara, Kosuke, Inoue, Hiroshi, Seki, NobuhikoEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
31por Lipton, Richard B., Baygani, Simin K., Tepper, Stewart J., Krege, John H., Vasudeva, Raghavendra, Pearlman, Eric M., Hauck, Paula M., Loo, Li Shen“…METHODS: Patient-level data were pooled across studies and treatment arms from two Phase 3 trials comparing lasmiditan and placebo, SAMURAI and SPARTAN. This post hoc analysis assessed freedom from the most bothersome symptom (MBS), freedom from migraine-related functional disability (disability), and improved patient global impression of change (PGIC) in patients who achieved 2 h pain freedom compared to those who experienced 2 h mild pain. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
32por Tanaka, Hisashi, Tanzawa, Shigeru, Misumi, Toshihiro, Makiguchi, Tomonori, Inaba, Megumi, Honda, Takeshi, Nakamura, Junya, Inoue, Koji, Kishikawa, Takayuki, Nakashima, Masanao, Fujiwara, Keiichi, Kohyama, Tadashi, Ishida, Hiroo, Kuyama, Shoichi, Miyazawa, Naoki, Nakamura, Tomomi, Miyawaki, Hiroshi, Oda, Naohiro, Ishikawa, Nobuhisa, Morinaga, Ryotaro, Kusaka, Kei, Fujimoto, Nobukazu, Fukuda, Yasushi, Yasugi, Masayuki, Tsuda, Takeshi, Ushijima, Sunao, Shibata, Kazuhiko, Shibayama, Takuo, Bessho, Akihiro, Kaira, Kyoichi, Shiraishi, Kenshiro, Matsutani, Noriyuki, Seki, NobuhikoEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
33
-
34por Hashimoto, Jun, Garnero, Patrick, van der Heijde, Désirée, Miyasaka, Nobuyuki, Yamamoto, Kazuhiko, Kawai, Shinichi, Takeuchi, Tsutomu, Yoshikawa, Hideki, Nishimoto, Norihiro“…This study was a subanalysis from a prospective 1-year, multicenter, X-ray-reader-blinded, randomized controlled trial of tocilizumab [Study of Active Controlled Monotherapy Used for Rheumatoid Arthritis, an IL-6 Inhibitor (SAMURAI) trial]. All patients were categorized into two or three groups according to four independent predictive markers for progressive joint damage [urinary C-terminal crosslinking telopeptide (uCTX-II), urinary pyridinoline/deoxypyridinoline (uPYD/DPD) ratio, body mass index (BMI), and joint-space narrowing (JSN) score at baseline]. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
35por Tanzawa, Shigeru, Makiguchi, Tomonori, Tasaka, Sadatomo, Inaba, Megumi, Ochiai, Ryosuke, Nakamura, Junya, Inoue, Koji, Kishikawa, Takayuki, Nakashima, Masanao, Fujiwara, Keiichi, Kohyama, Tadashi, Ishida, Hiroo, Kuyama, Shoichi, Miyazawa, Naoki, Nakamura, Tomomi, Miyawaki, Hiroshi, Oda, Naohiro, Ishikawa, Nobuhisa, Morinaga, Ryotaro, Kusaka, Kei, Miyamoto, Yosuke, Yokoyama, Toshihide, Matsumoto, Chiaki, Tsuda, Takeshi, Ushijima, Sunao, Shibata, Kazuhiko, Shibayama, Takuo, Bessho, Akihiro, Kaira, Kyoichi, Misumi, Toshihiro, Shiraishi, Kenshiro, Matsutani, Noriyuki, Seki, Nobuhiko“…CONCLUSION: Regarding durvalumab after CRT, this interim analysis of the SAMURAI study clarified the high transition rate, early introduction, and reasons for failure to proceed to consolidation therapy, which were not determined in the PACIFIC trial. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
36por Canabarro, Askery, Tenório, Elayne, Martins, Renato, Martins, Laís, Brito, Samuraí, Chaves, RafaelEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37
-
38
-
39
-
40por Smith, Timothy, Krege, John H., Rathmann, Suchitrita S., Dowsett, Sherie A., Hake, Ann, Nery, Emel S. M., Matthews, Brandy R., Doty, Erin G.“…Pooled data from SAMURAI and SPARTAN (SAMURAI + SPARTAN) and data from GLADIATOR were analyzed using the intention-to-treat populations. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto